We report the case of a 43 year old man with multiple endocrine neoplasia (Zollinger-Ellison syndrome-hyperparathyroidism) diagnosed during investigations for a severe ulcer with diarrhoea. The history suggested Zollinger-Ellison syndrome, especially as basal acid production and blood gastrin levels were high. Hypercalcaemia and low blood phosphate levels suggested hyperparathyroidism, which was confirmed by ultra-sound of the neck, showing two parathyroid adenomas. The aim of treatment was two-fold: suppress the hyperparathyroidism and treat the Zollinger-Ellison syndrome. The approach is surgical in most cases, but the tumour is often impossible to remove and total gastrectomy has become rare with the progress in anti-secretory therapy. When the tumour behind a case of Zollinger-Ellison syndrome cannot be found, complementary chemotherapy is indicated. Other endocrine lesions must always be sought and the family investigated to exclude Wermer syndrome.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
First reported case of multiple endocrine neoplasia type 1 in an Australian Aboriginal.
Endocrinol Diabetes Metab Case Rep
July 2024
Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
Article Synopsis
- - The case study discusses a 48-year-old Aboriginal Australian woman diagnosed with Multiple Endocrine Neoplasia type 1 (MEN1), who faced significant health issues including hypercalcaemia, following a history of parathyroid surgery and several severe medical conditions, indicating the complexity of her case.
- - Genetic testing revealed a rare variant in the MEN1 gene, but cultural and logistical challenges hindered effective genetic counseling for her family, highlighting gaps in healthcare support for remote Aboriginal communities.
- - The case underscores the critical need for improved genetic counseling approaches and timely recognition of rare diseases in remote areas, as late diagnoses can lead to severe health consequences, as seen in her unfortunate passing in 2021.
Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.
Int J Mol Sci
July 2024
Digestive Diseases Branch, NIDDK, NIH, Bethesda, MD 20892-1804, USA.
Article Synopsis
- * A study of 175 ZES patients showed that 21% had vitamin B deficiency after an average of 10.2 years of treatment, particularly correlating with extremely low acid control rates.
- * The findings indicate that chronic PPI use results in significant acid reduction, which negatively impacts vitamin B levels and body stores, increasing the risk of deficiency.
Presentation, Diagnosis, and Treatment of a Sporadic Gastrinoma With Liver Metastases.
Cureus
May 2024
General Surgery, Brookdale University Hospital Medical Center, Brooklyn, USA.
Article Synopsis
- - A gastrinoma is a rare but serious tumor that produces gastrin, which can cause symptoms like anemia, weight loss, and diarrhea, complicating early detection.
- - These tumors often spread to the liver, and surgery is typically necessary to remove both the primary tumor and any metastases for a chance at a cure.
- - This report discusses a case involving a 59-year-old woman with anemia and gastrointestinal bleeding, revealing a pancreatic gastrinoma with extensive liver metastases, along with the treatment approach taken to improve her survival odds.
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients.
Eur J Hosp Pharm
December 2024
Department of Electronic Engineering, Tsinghua University, Beijing, China
Article Synopsis
- The study aimed to create a system (PPI-MS) that monitors the clinical use of proton pump inhibitors (PPIs) in hospitalized adults, enhancing the detection of inappropriate usage.
- Researchers used natural language processing to analyze patient records and identify both therapeutic and preventive applications of PPIs, reviewing 9421 cases from July 2022 to July 2023.
- Results showed that over 50% of PPIs were used for prophylaxis, with nearly half deemed inappropriate, mainly due to lack of indications, and the monitoring system demonstrated a high accuracy and efficiency compared to manual tracking methods.
Middle-segment preserving pancreatectomy: a literature review and case report.
Langenbecks Arch Surg
June 2024
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
Article Synopsis
- Middle segment-preserving pancreatectomy (MSPP) is a newer surgical option for treating benign and borderline pancreatic diseases, offering an alternative to total pancreatectomy (TP), with only 36 reported cases so far.
- In a case study of a 49-year-old man with Zollinger-Elison syndrome, MSPP was successfully performed, resulting in a postoperative pancreatic fistula that improved with conservative care, and no tumor recurrence was observed.
- Although MSPP has a high morbidity rate (54%) primarily due to complications like pancreatic fistula, it shows low mortality rates and maintains pancreatic function similar to traditional surgeries.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!